The efficacy and safety of topiramate for prophylaxis of migraine in children

Iranian Journal of Child Neurology

Volumn 7, Issue 4, 2013, Pages 7-11

  Fallah, Razieh ^a   Akhavan Karbasi, Sedighah ^a   Shajari, Ahmad ^b   Fromandi, Mostafa ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Headache; Migraine; Prophylaxis; Topiramate

Indexed keywords

TOPIRAMATE;

AGE; ANOREXIA; ARTICLE; BODY WEIGHT; CHEMOPROPHYLAXIS; CHILD; DISEASE DURATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTHERMIA; MAJOR CLINICAL STUDY; MALE; MIDAS (MIGRAINE); MIGRAINE; ONSET AGE; QUASI EXPERIMENTAL STUDY; SCHOOL CHILD; SIDE EFFECT;

EID: 84887738526     PISSN: 17354668     EISSN: 20080700     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hershey AD. Migraine. In: Kliegman RM, Stanton BF, Schor NF, St. Geme JW, Behrman RE, editors Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders; 2011. p. 2040-5.
2. The International Classification of Headache Disorders: 2nd ed. Headache Classification Subcommittee of the International Headache Society. Cephalalgia 2004;24 Suppl 1:9-160.
3. Hershey AD, Winner PK. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc 2005;105(4 Suppl 2):2S-8S.
4. Jayapal S, Maheshwari N. Question 3. Topiramate for chronic migraine in children. Arch Dis Child 2011;96(3):318-21.
5. Fallah R. Topiramate as a new antiepileptic drug in epileptic children in Iran. Indian J Pediatr 2006;73(12):1073-5.
6. Hershey AD, Powers SW, Vockell ALB, LeCates SL, Kabbouche MA, Maynard MK. PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology 2001;57(11):2034-9.
7. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990;13(4):227-36.
8. Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand 2008;118(5):301-5.
9. Tonekaboni SH, Ghazavi A, Fayyazi A, Khajeh A, Taghdiri MM, Abdollah Gorji F, Azargashb E. Prophylaxis of childhood migraine: Topiramate versus Propranolol. Iran J Child Neurol 2013; 7(1):9-14.
10. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45(10):1304-12.
11. Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123(3):924-34.
12. Borzy JC, Koch TK, Schimschock JR. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol 2005;33(5):314-6.
13. Campistol J, Campos J, Casas C, Herranz JL. Topiramate in the prophylactic treatment of migraine in children. J Child Neurol 2005;20(3):251-3.
14. Cruz MJ, Valencia I, Legido A, Kothare SV, Khurana DS, Yum S, et al. Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol 2009;41(3):167-70.
15. Aydin M, Kabakus N, Bozdag S, Ertugrul S. Profile of children with migraine. Indian J Pediatr 2010;77(11):1247-51.
16. Unalp A, Uran N, Oztürk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol 2008;23(12):1377-81.
17. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 2007;22(7):829-35.
18. Vollono C, Ferraro D, Valeriani M. Antiepileptic drugs in the preventive treatment of migraine in children and adolescents. Drug Development Research 2007;68:355-9.
19. Ferraro D, Di Trapani G. Topiramate in the prevention of pediatric migraine: literature review. J Headache Pain 2008;9(3):147-50.